Find a lawyer, find an attorney Neurontin Lawyer
 Find Lawyers and Legal Information Neurontin Lawyer
   Find a Lawyer | Featured Law Firms | Legal Products & Support | Legal News | Legal Forms | Contact | For Attorneys  

Neurontin Lawyer

LawyerFinder.com is a FREE consumer service. We are NOT a law firm.  We assist consumers in locating Neurontin Lawyers and law firms in specific regions.

We provide comprehensive law firm profiles so that you can review, screen and learn more about our members prior to contacting an attorney.  In many cases our Neurontin Lawyer members provide useful articles and example cases to aid you in intelligently choosing the most appropriate legal representation for your unique situation.

To locate a Neurontin Lawyer, simply choose a state from the form to the top right or choose the link from the left hand menu of this page.

Gabapentin (brand name: Neurontin®) is an anticonvulsant medication indicated in the treatment of epilepsy and neuropathic pain. Gabapentin is known for having a relatively mild side effect profile, and passes through the body unmetabolized.

Gabapentin is similar in structure to the neurotransmitter GABA but is not believed to act on the same brain receptors. Its exact mechanism of action is unknown, but its therapeutic action on neuropathic pain is thought to involve voltage gated calcium ion channels.

Gabapentin has also been used in the treatment of bipolar disorder. However the FDA has never approved gabapentin for the treatment of bipolar disorder, and its use for this purpose is increasingly controversial. Some claim gabapentin acts as a mood stabilizer and has the advantage of having fewer side effects than more conventional bipolar drugs such as lithium and depakote. Some small, non-controlled studies in the 1990s, most sponsored by gabapentin's manufacturer, suggested that gabapentin treatment for bipolar disorder may be promising. However, more recently, several larger, controlled, and double-blind studies have found that gabapentin was no more effective than (and in one study, slightly less effective than) placebo, and the manufacturer has even halted its own studies regarding gabapentin and bipolar disorder. Despite this scientific evidence against the efficacy of gabapentin in the treatment of bipolar disorder, many psychiatrists continue to prescribe it for this purpose.

Gabapentin has also been used (also without FDA approval) in the treatment of anxiety disorders such as social anxiety disorder and obsessive-compulsive disorder, in treatment-resistant depression, and for insomnia. Gabapentin may be effective in reducing pain and spasticity in multiple sclerosis. In addition to its use in mood disorders, gabapentin was approved by the FDA for treating postherpetic neuralgia (neuropathic pain following shingles).

Gabapentin is best known under the brand name Neurontin manufactured by Pfizer . In October 2004, FDA approved a generic equivalent to Neurontin made by Israeli firm Teva. Neurontin is one of Pfizer's best selling drugs, and was one of the 50 most prescribed drugs in the United States in 2003. However, in recent years Pfizer has come under heavy criticism for its marketing of Neurontin, facing allegations that behind the scenes Pfizer marketed the drug for at least a dozen supposed uses for which the drug had not been FDA approved. By some estimates, so-called "off-label" prescriptions account for roughly 90% of Neurontin sales. While off-label prescriptions are common for a number of drugs and are perfectly legal (if not always appropriate), marketing for off label uses of a drug is strictly illegal. In 2004, Pfizer agreed to pay a $430 million settlement for the illegal marketing of Neurontin for off-label purposes, and further legal action is pending.

Pfizer is developing a successor to gabapentin, called pregabalin, which Pfzier hopes will be approved for use in epilepsy and neuropathic pain, as well as some of gabapentin's off label uses, especially anxiety disorders.

Gabapentin's main side effect is drowsiness. Fortunately, in most cases, the drowsiness subsides after a few days, but the therapeutic effects persist.

(this article compliments of Wikipedia)

Find Neurontin Lawyers. Click on the state below:

Alabama Neurontin Lawyer
Alaska Neurontin Lawyer
Arizona Neurontin Lawyer
Arkansas Neurontin Lawyer
California Neurontin Lawyer
Colorado Neurontin Lawyer
Connecticut Neurontin Lawyer
Delaware Neurontin Lawyer
Florida Neurontin Lawyer
Georgia Neurontin Lawyer
Hawaii Neurontin Lawyer
Idaho Neurontin Lawyer
Illinois Neurontin Lawyer
Indiana Neurontin Lawyer
Iowa Neurontin Lawyer
Kansas Neurontin Lawyer
Kentucky Neurontin Lawyer
Louisiana Neurontin Lawyer
Maine Neurontin Lawyer
Maryland Neurontin Lawyer
Massachusetts Neurontin Lawyer
Michigan Neurontin Lawyer
Minnesota Neurontin Lawyer
Mississippi Neurontin Lawyer
Missouri Neurontin Lawyer
Montana Neurontin Lawyer
Nebraska Neurontin Lawyer
Nevada Neurontin Lawyer
New Hampshire Neurontin Lawyer
New Jersey Neurontin Lawyer
New Mexico Neurontin Lawyer
New York Neurontin Lawyer
North Carolina Neurontin Lawyer
North Dakota Neurontin Lawyer
Ohio Neurontin Lawyer
Oklahoma Neurontin Lawyer
Oregon Neurontin Lawyer
Pennsylvania Neurontin Lawyer
Rhode Island Neurontin Lawyer
South Carolina Neurontin Lawyer
South Dakota Neurontin Lawyer
Tennessee Neurontin Lawyer
Texas Neurontin Lawyer
Utah Neurontin Lawyer
Vermont Neurontin Lawyer
Virginia Neurontin Lawyer
Washington DC Neurontin Lawyer
Washington Neurontin Lawyer
West Virginia Neurontin Lawyer
Wisconsin Neurontin Lawyer
Wyoming Neurontin Lawyer

 

Our goal with the Neurontin section of LawyerFinder.com is to try and help legal consumers get in touch with legal professionals practicing Neurontin law, such as: Neurontin lawyers, Neurontin law firm or Neurontin attorneys.

Neurontin News

Teva Receives First U.S. Approval For Generic Risperdal(R) Tablets; Commences Commercial Launch (Medical News Today)
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) announced that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Janssen's antipsychotic agent Risperdal® (Risperidone) Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg. Shipment of these products has commenced.

Teva Provides Update on Generic Seroquel(R) Litigation (Centre Daily Times)
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. District Court for the District of New Jersey has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version of AstraZeneca's Seroquel(R) (Quetiapine) Tablets. The Court granted summary judgment in AstraZeneca's favor on the issue of no inequitable ...

Teva Provides Update on Generic Seroquel(R) Litigation (Business Wire via Yahoo! Finance)
JERUSALEM----Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of New Jersey has issued a decision in its litigation over the Company's Abbreviated New Drug Application to market its generic version of AstraZeneca's Seroquel® Tablets.

The medicine cabinet: Treating fibromyalgia (Newsday)
What is the best and safest painkiller I can use long term for fibromyalgia? I suffer from severe headaches, muscle and joint pain, as well as back pain.

Teva Receives First U.S. Approval for Generic Risperdal(R) Tablets; Commences Commercial Launch (Centre Daily Times)
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Janssen's antipsychotic agent Risperdal(R) (Risperidone) Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg. Shipment of these products has commenced.


Legal News provided by Yahoo! News!

Legal Marketplace

Expert Witnesses | Practice Support | Court Reporter | Process Server | Bail Bonds | Legal Investigator | Legal Software | Legal Technology | ADR (Alternative Dispute Resolution)

Home | About Us | Privacy & Disclaimer | Contact Us | Add your firm | Advertise

Affiliate Program | Affiliate Login | Firm Login

The purpose of LawyerFinder.com is to provide a listing of attorneys and experts and access to legal information and resources. WE DO NOT PROVIDE LEGAL ADVICE. We strive to make sure that the content provided on this site is as up-to-date and as accurate, as possible. However, we do not guarantee that ALL information is current since laws and information tends to change on a regular basis.

Listings by lawyers, businesses and experts on LawyerFinder.com are provided strictly by the lawyers,businesses or experts themselves. Although, we attempt to validate each listing before adding to the database, LawyerFinder.com is not responsible for errors and inaccuracies in listings or misrepresentation by listing professionals.. When viewing a listing, consider the state advertising rules to which lawyers and law firms must adhere and see our disclaimer & privacy policy.

©1997-2007 Trumpet Marketing Group,LLC

Legal Practice Pages provided by LegalMarketingPros.com

LawyerFinder®, Legal PracticePages™ and LifeTime Legal Links™ are trademarks of Trumpet Marketing Group, LLC. All rights reserved.